edaravone has been researched along with Long QT Syndrome in 1 studies
Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Shimizu, H | 1 |
Inoue, S | 1 |
Endo, M | 1 |
Nakamaru, Y | 1 |
Yoshida, K | 1 |
Natori, T | 1 |
Kakubari, M | 1 |
Akimoto, M | 1 |
Kondo, K | 1 |
1 trial available for edaravone and Long QT Syndrome
Article | Year |
---|---|
A Randomized, Single-Blind, Placebo-Controlled, 3-Way Crossover Study to Evaluate the Effect of Therapeutic and Supratherapeutic Doses of Edaravone on QT/QTc Interval in Healthy Subjects.
Topics: Adult; Cross-Over Studies; Edaravone; Electrocardiography; Free Radical Scavengers; Healthy Voluntee | 2021 |